Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember 2012

Embed Size (px)

Citation preview

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    1/32

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    2/32

    IC^A]K PALC^KHCODLKOKDCL PC^HUC[T ]TQN N] IJHCICN TQUCONKA

    GJ^C TQ]CMC[CBCUC ^KIQ]

    N}/ Njn{ Fk}iconc, Tp/C, ICTq}cmc{c, 8 ; Nataima} =03=

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    3/32

    k

    Ncf~c} Ktk

    HclcicoPaonchqlqco Dlkokdcl Pc~huc{t 3

    Icofcc~ Dlkokdcl Pc~huc{t nc}k taek Afktkaotk Paimkc{cco, Afag~kfk~ct Palc{coco ncoGama}cnklco*Agqk~k nclci ^c~c Galjlc Glkokt (Dlkokdcl Ejva}ocoda+ nco Tkt~aiPaimkc{cco Dctaikx

    T~conc} Palc{coco Ganjg~a}co (TPG+, Panjico Octkjocl Palc{cocoGanjg~a}co (POPG+, T~conc} P}jtanq} Jpa}ctkjocl (TPJ+ nco PconqcoP}cg~kg Glkokt (PPG+Pa}co Dlkokdcl Pc~huc{t nclci Iq~q nk ]qich Tcgk~Pa}co Dlkokdcl Pc~huc{t nclci Paonknkgco Gatahc~co*Ganjg~a}co nk ]qichTcgk~Pa}co Dlkokdcl Pc~huc{t nclci Paoalk~kco Gatahc~co*Ganjg~a}co nk ]qichTcgk~Icofcc~ Dlkokdcl Pc~huc{t nclci Cg}ank~ctk ]qich Tcgk~

    >

    P}kotkp P}kotkp nclci Iao{qtqo Dlkokdcl Pc~huc{t =4

    Lcoegch Lcoegch Pao{qtqoco Dlkokdcl Pc~huc{t =>

    Pa}tkcpco nclci Pao{qtqoco Dlkokdcl Pc~huc{t =1

    Gatkipqlco =6

    Lcipk}co2Fj}ic~ Pconqco P}cg~kg Glkokt (PPG+ ]TQN N} Ijhcicn Tquconka =8

    Fj}ic~ Qiqi Dlkokdcl Pc~huc{t ]TQN N} Ijhcicn Tquconka 40

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    4/32

    3

    Dlkokdcl Pc~huc{t $

    Njn{ Fk}iconcGa~qc Gjik~a Iankg ]TQP Fc~icuc~k, Bcgc}~c/

    Paonchqlqco

    Nclci ialcgqgco avclqctk gamkbcgco nco tkt~ai lc{coco gatahc~co ( hacl~hdc}a t{t~ai

    con pjlkdkat avclqc~kjo+ ~a}ictqg }qcich tcgk~ cnc 4 g}k~a}kc gqodk {cgok g}k~a}kc

    afag~kfk~ct, afktkaotk, nco gama}cnklco*agqk~k(affad~kvaoatt, affkdkaod{ con asqk~{+3 {coe

    ia}qpcgco tqc~q }coegckco tkt~aic~kg nclci tqc~q tkt~ai/ Ialcgqgco tqc~q coclktkt

    agjojik nclci palc{coco ganjg~a}co p}jfatk cnclch ~kncg iqnch, iaoekoec~ mco{cg

    fcg~j} {coe hc}qt nkpa}~kimcoegco nc}k ma}mceck nkiaotk ~a}ictqg dc}c paonagc~co nc}k

    baokt coclktkt agjojik {coe cgco nkeqocgco, mc~ctco ~a}ikojljek agjojik k~q taonk}k

    iaoeaock q~klkrc~kjo, p}jnqd~kvk~{, maoafk~, affkdkaod{, affad~kvaoatt, vclqa fj} ijoa{,

    gamkbcgco fktgcl nco ~koegc~koflc~kjo }c~a {coe ta}koe gclk ma}qmch/ Nktcipkoe

    ga~a}mc~ctco tqima} nc{c nco gamkbcgco agjojik {coe nkpaoec}qhk pjlk~kt, tahkoeec

    ~kncg bc}coe%}atjq}dat% ~a}tamq~ ~alch nkpceq iaobcnk%fkxan% /=

    Tancoegco nk tktk nkiaotk lcko p}jfatk k~q taonk}k nk~qo~q~ qo~qg iaokoegc~gco iq~q

    palc{cocoo{c nco gap}jfatkcoo{c nclci gj}knj} a~kg)tjtkj)mqnc{c ta}~c ma}mceck

    pa}c~q}co nco pa}qoncoeco hqgqi/ 5 Pctcl >1 nclci Qoncoe Qoncoe ]K Ojij} =;

    ^chqo =00> ~ao~coe P}cg~kg Ganjg~a}co pcnc iaoa}coegco ~ao~coe gaucbkmco

    iao{alaoeec}cgco gaonclk iq~q nco gaonclk mkc{c 4 nco Qoncoe Qoncoe ]K Ojij}

    $ Nktcipckgco pcnc Uj}gthjp Dlkokdcl Pc~huc{t ]TQN N} Ijhcicn Tquconka Tq}cmc{cBcuc ^kiq} 8 ) ; Nataima} =03=/

    3 Cnc{ LC, Maela{ DA, Lck}tjo N]/ Avclqc~koe ~ha hacl~hdc}a t{t~ai2 affad~kvaoatt, affkdkaod{ conasqk~{/ 4}n an/ Ucthkoe~jo ND2 Hacl~h Cnikokt~}c~kjo P}att, =00>/

    = Fk}iconc N/ Cplkgctk ko~ae}ctk tkoa}ekt co~c}cAvknaova)mctan Iankdkoa, Avknaoda)mctan Hacl~hdc}a nco Avknaoda)mctan Pjlkd{ nclci tc~q tkt~ai paokoegc~co iq~q palc{coco gatahc~co nco ganjg~a}co(Dlkokdcl Ejva}ocoda+2 tqc~q ~co~coeco p}jfatk KNCK nk ictc iaonc~coe/KK/Djt~ Affad~kvaoatt Cocl{tat(DAC+T~conc} Palc{coco Iankt (TPI+ Gatahc~co Cocg KNCK Nktcipckgco pcnc Cdc}c Pa}~aiqcoPa}hkipqoco J}ecoktctk P}jfatk naoeco Nk~bao [co Iankg Napgat ]K nk Mjej} Tap~aima} =001/h~~p2**uuu/td}kmn/dji*njd*3=8=5;46*Njn{)Fk}iconc)=001)0>=)Cplkgctk)ko~ae}ctk)tkoa}ekt)

    Avknaovamctan)Iankdkoa)Avknaodamctan)Hacl~hdc}a)nco)Avknaodamctan)Pjlkd{)nclci)Dlkokdcl)Ejva4 Qoncoe Qoncoe ]K Ojij} =; ^chqo =00> ~ao~coe P}cg~kg Ganjg~a}co

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    5/32

    =

    >> ^chqo =030 ~ao~coe ]qich Tcgk~ pcnc pctcl 44 iaoa}coegco ~ao~coe j}ecoktctk

    }qich tcgk~ {coe afag~kf, afktkao, nco cgqo~cmal / >

    Tancoegco nclci paoealjlcco gaqcoeco ~alch cnc Pa}c~q}co Paia}ko~ch Ojij} =4

    ^chqo =001 ~ao~coe Paoealjlcco Gaqcoeco Mcnco Lc{coco Qiqi nco Pa}c~q}co

    Iao~a}k Nclci Oaea}k Ojij} 63 ^chqo =005 ~ao~coe Panjico ^agokt Paoealjlcco

    Gaqcoeco Mcnco Lc{coco Qiqi Nca}ch pcnc pctcl 3 c{c~ 3 iao{amq~gco qo~qg

    iaima}kgco palc{coco gapcnc ict{c}cgc~ ma}qpc pao{ankcco mc}coe nco*c~cq bctc {coe

    nkbqcl ~copc iaoeq~cicgco iaodc}k gaqo~qoeco nco nclci ialcgqgco gaekc~coo{c

    nknctc}gco pcnc p}kotkp afktkaotk nco p}jnqg~kvk~ct /1,6

    Naoeco ~a}mk~o{c Qoncoe Qoncoe ]apqmlkg Konjoatkc Ojij} => ^chqo =033 ~ao~coe

    Mcnco Pao{alaoeec}c Bcikoco Tjtkcl (MBPT+ 5/ Tatqck naoeco cicoc~ pa}qoncoeco

    ~a}tamq~ ) pa}c~q}co iaoeaock palcgtcocco MPBT Gatahc~co hc}qt ~alch cnc pclkoe lcic

    ~coeecl =1 Ojvaima} =03= (3 ~chqo nc}k nkqoncoegcoo{c+ 8 nco tqnch hc}qt iqlck

    ma}jpa}ctk pcnc ~coeecl 3 Bcoqc}k =03>; ta}~c qo~qg MPBT Gatahc~co30 ~kncg

    nktalaoeec}cgco lcek jlah Gaiao~a}kco Gatahc~co 33 / Pa}~co{cco {coe ~kimql cnclch

    mceckicoc tkt~ai MPBT Gatahc~co ~a}tamq~:

    Avjlqtk tkt~ai lc{coco gatahc~co nk tc}coc gatahc~co (}qich tcgk~+ tadc}c p}kotkpo{c

    iqlck nc}k {coe ma}dk}kgco njkoe ~hkoet dhacpa} nclci hcl kok affkdkaod{pcnc ~chqo

    3;50co pcnc ucg~q g}ktkt gaqcoeco nco eabjlcg JPAD, gaiqnkco agjojik iqlck pqlkh

    nco ict{c}cgc~ iaoqo~q~ lc{coco gatahc~co ma}dk}kgco njkoe ~hkoet ma~~a} nclci hcl

    koksqclk~{ kip}jvaiao~ / Talcic nqc nagcna ~a}tamq~ icocbaiao ma}dj}cg njkoe ~hkoet

    }keh~ (nkgaocl tamceck kod}actkoe affad~kvaoatt+{coe ia}qpcgco gjimkoctk njkoe

    > Qoncoe Qoncoe ]K Ojij} >> ^chqo =030 ~ao~coe ]qich Tcgk~1 Pa}c~q}co Paia}ko~ch ]K Ojij} =4 ^chqo =001 ~ao~coe Paoealjlcco Gaqcoeco Mcnco Lc{coco Qiqi6 Pa}c~q}co Iao~a}k Nclci Oaea}k Ojij} 63 ^chqo =005 ~ao~coe Panjico ^agokt Paoealjlcco Gaqcoeco

    Mcnco Lc{coco Qiqi Nca}ch5 Qoncoe Qoncoe ]K Ojij} => ^chqo =033 ~ao~coe Mcnco Pao{alaoeec}c Bcikoco Tjtkcl8 Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 50 c{c~ c/; Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 60 c{c~ (3+/30 Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 1 c{c~ (=+c/33 Qoncoe Qoncoe ]K Oj/=> ^chqo =033 Pctcl 60 c{c~ (=+c/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    6/32

    4

    ~hkoet dhacpa} nco njkoe ~hkoet ma~~a}/ a}o{c~c p}kotkp njkoe ~hkoet }keh~ ~kncg

    iaicnck iaoekgq~k pa}gaimcoeco gaicbqco ~agojljek icqpqo ~qo~q~co ict{c}cgc~

    {coe taicgko g}k~kt7 nco p}kotkp icocbaiao njkoe ~hkoet }keh~ ~a}tamq~ ~alch

    ga~koeeclco rcico nco nkcoeecp tamceck p}kotkp nco dc}c icocbaiao gqoj/ Pcnc cmcn =3

    kok ictc a}c eljmclktctk nkmq~qhgco ~kncg hco{c njkoe ~hkoet }keh~, cgco ~a~cpk bqec

    nkpa}lqgco p}kotkp icocbaiao njkoe ~ha }keh~ ~hkoet tahkoeec gjimkoctk ganqco{c

    nktamq~ tamceck p}kotkp icocbaiao lc{coco ijna}o njkoe ~ha }keh~ ~hkoet }keh~ / 3=

    Icofcc~ Dlkokdcl Pc~huc{t nclci Afktkaotk Paimkc{cco, Afag~kfk~ct Palc{coco ncoGama}cnklco*Agqk~k

    Dlkokdcl Pc~huc{t (DP+ cnclch tqc~q gjotap pa}aodcocco palc{coco ~a}pcnq {coe

    ia}coegqi ta~kcp lcoegch {coe nkma}kgco gapcnc pctkao ma}nctc}gco t~conc}

    palc{coco iankt nco ctqhco gapa}cuc~co {coe ma}mctkt mqg~k naoeco hctkl {coe ~a}qgq}

    nco nclci bcoegc ucg~q ~a}~ao~q talcic nk }qich tcgk~/ 34,3>,31

    Ma}kgq~ hctkl paoalk~kco paoa}cpcoDlkokdcl Pc~huc{t Poaqijokc (Ecimc} 3 nco =+ {coe

    nklcgqgco nclci }coegc iaimqg~kgco cnco{c afktkaotk mkc{c, afag~kfk~ct lc{coco nco

    gama}cnklco*agqk~k mcek taiqc pctkao ~copc iaiconcoe lc~c} malcgcoe gacncco tjtkcl

    agjojik, paonknkgco icqpqo eaona}/ Nc}k Ecimc} 3 nco = nk mcuch qo~qg gctqt

    poaqijokc mkc{c pa}cuc~co tcipck taimqh (naoeco ~c}kf }qich tcgk~+ iaipa}eqocgco

    Dlkokdcl Pc~huc{t Poaqijokc cnclch tagk~c} ]p >;1 000,) qo~qg galct KKK, ]p 3 3=0 000,)

    qo~qg galct KK, ]p 3 >80 000,) qo~qg galct K nco ]p = 310 000,) qo~qg galct VKP/

    3= Fk}iconc N/ Pa}co Afag~kfk~ct Glkokt nclci }coegc iauqbqngco gatalcic~co*gacicoco (tcfa~{+ nco ma}j}kao~ctk gapcnc pctkao (pc~kao~ dao~}anoatt+/Nktcipckgco pcnc Hjtpk~cl Icoceaiao~ 4 {coenktalaoeec}cgco jlah Pqtc~ Gcbkco Cnikokt~}ctk nco Gamkbcgco Gatahc~co FGI QK nk E}con CoegctcHj~al Ko~a}oc~kjocl, Ianco 33 Ceqt~qt =008/ h~~p2**uuu/td}kmn/dji*njd*;834333*Njn{)Fk}iconc)=008)

    Pa}co)Afag~kvk~ct)Glkokt)Nclci)PC^H34 Fk}iconc N/ Panjico Pao{qtqoco Dlkokdcl Pc~huc{t nclci }coegc kiplaiao~ctk Tkt~ai N]Et

    Dctaikx nk }qich tcgk~/ Nktcipckgco nclci Tkncoe Plaoj Gjik~a Iankg ]T Fc~icuc~k, Bcgc}~c 5Jg~jma} =001/

    3> Fk}iconc N/ Dlkokdcl Pc~huc{t2 Pa}co p}jfatk iankt nclci }coegc iao{qtqo Tkt~ai N]Et Dctaikx nk}qich tcgk~/ Nktcipcgco pcnc gqobqoeco lcpcoeco ga ]TQP Cnci Iclkg Ianco == Nataima} =001,]TQP Hctco Tcnkgko Mconqoe =4 Nataima} =001 nco Avclqctk Pao{qtqoco Dlkokdcl Pc~huc{t nclci}coegc pao{aipq}occo Panjico N]Et Dctaikx Napgat ]K, Hj~al E}con Daipcgc Bcgc}~c =;Nataima} =001/

    31 Fk}iconc N, P}c~kuk Conc{cok, Oq}ckok K}ic Tqtco~k, T}ka Aoeec} GN ngg/ Dlkokdcl Pc~huc{tGatahc~co Cocg nclci }coegc kiplaiao~ctk Tkt~ai N]Et Dctaikx nk ]T Fc~icuc~k, Bcgc}~c =006/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    7/32

    >

    Tancoegco mklc nkhk~qoe ma}nctc}gco glcki Bcigatict qo~qg gctqt {coe tcic cnclch ]p

    = 505 664,)/ Icgc tadc}c ic~aic~kg naoeco iaipa}eqocgco Dlkokdcl Pc~huc{t qo~qg

    gctqt poaqijokc ~a}tamq~ iaoehaic~ (= 505 664 >;1 000 9 ]p = =3= 664,)+/ Naoeco

    naikgkco ~a}lkhc~ balct nc}k taek agjojik*paimkc{cco }qich tcgk~ ~a}tamq~ tcoec~ afktkao

    nco iaoeqo~qoegco mklc iaoeeqocgco Dlkokdcl Pc~huc{t /

    Naoeco iaipa}eqocgco Dlkokdcl Pc~huc{t ncpc~ iaoehk~qoe Djt~ Uakeh~ ta~kcp

    galjipjg gctqt, djo~jh qo~qg gctqt poaqijokc nk c~ct }a}c~c tqima}nc{c (}atjq}dat+

    }qich tcgk~ (jmc~ jmc~co, mchco nco clc~ nll+ {coe ~a}pcgck cnclch]p =10 000,) icgc

    Djt~)Uakeh~ o{c cnclch (>10 000*=10 000 9 3/8+ /

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    8/32

    1

    Ecimc} 3/ Djo~jh hctkl paoalk~kco kiplaiao~ctk tclch tc~q Dlkokdcl Pc~huc{t qo~qg gctqt poaqijokc

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    9/32

    6

    Ecimc} =/ Djo~jh coclktkt hctkl kiplaiao~ctk tclch tc~q Dlkokdcl Pc~huc{t pcnc~chqo =006 qo~qg gctqt poaqijokc

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    10/32

    5

    ^ao~coe dc}c lcoegch lcoegch pa}hk~qoeco djt~ uakeh~, dctaikx konax, mcta }c~a

    }qich tcgk~ nco cljgctk coeec}co ncpc~ nklkhc~ nclci Ecimc} 4 ma}kgq~/

    Ecimc} 4/ Djo~jh pa}hk~qoeco ma}nctc}gco nc~c hctkl kiplaiao~ctk Dlkokdcl Pc~huc{t nclci iaodc}k ]alc~kva Uakeh~ (djt~ uakeh~+, Dcta Ikx Konax nco Mcta ]c~a /

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    11/32

    8

    Cec} ~kncg ~qipcoe ~konkh ta}~c tkoa}ekt naoeco gao{c~cco nk lcpcoeco (}qich

    tcgk~+, icgc kiplaiao~ctk Dlkokdcl Pc~huc{t tamckgo{c ~a}pcnq naoeco ~c~cgaljlc

    icocbciao (dj}pj}c~a ejva}ocoda+ nco ~c~cgaljlc glkokt (dlkokdcl ejva}ocoda +

    {coe ~alch ma}lcgq tatqck iktk }qich tcgk~ nclci mkncoe palc{coco, paonknkgco

    nco paoalk~kco/

    Naoeco ~a}mk~o{c Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij}

    34>8*IAOGAT*PA]*KX*=030 {coe nkeqocgco cnclch kt~klch T~conc} Palc{coco

    Ganjg~a}co (TPG+ {coe ~a}nk}k nc}k Panjico Octkjocl Palc{coco Ganjg~a}co

    (POPG+ nco T~conc} P}jtanq} Jpa}ctkjocl (TPJ+/ POPG nkmqc~ jlah j}ecoktctk p}jfatk nco nktchgco jlah Iao~a}k Gatahc~co ]K, tancoegco TPJ nkmqc~ nk ~koegc~

    }qich tcgk~ jlah p}jfatk iankt naoeco gjj}nkoc~j} Gjik~a Iankt nco nk~a~cpgco

    paoeeqoccoo{c nk }qich tcgk~ ~a}tamq~ jlah pkipkoco (nk}ag~q}+/

    T~conc} P}jtanq} Jpa}ctkjocl qo~qg p}jfatk iankt nk }qich tcgk~ nclci mao~qg

    Pconqco P}cg~kg Glkokt36 ) pcnc qiqio{c ncpc~ nkcnjptk nc}k Pconqco Octkjocl

    Palc{coco Ganjg~a}co (POPG+ {coe ~alch nkmqc~ jlah j}ecoktctk p}jfatk ictkoe

    ictkoe, ~koeecl nkdjdjggco nco nktatqckgco naoeco gjonktk tc}coc nco

    gjipa~aotk {coe cnc nk }qich tcgk~/ Mklc POPG {coe ~alch nkmqc~ jlah j}ecoktctk

    p}jfatk ~a}tamq~ nco ~alch nktchgco jlah Iao~a}k Gatahc~co ]K ta}~c tatqck naoeco

    gjonktk }qich tcgk~ icgc ~koeecl nktapcgc~k jlah coeej~c p}jfatk (TIF+ ~a}gck~

    tamceck Pconqco P}cg~kg Glkokt (PPG+ nco nktchgco paoeeqoccoo{c nk }qich

    tcgk~ jlah nk}ag~q} }qich tcgk~ ~a}tamq~/

    Ociqo mklc POPG ~a}tamq~ malqi cnc c~cq ~kncg tatqck naoeco gjonktk }qich

    tcgk~ c~cq nclci POPG malqi iaodco~qigco baokt pao{cgk~ {coe tatqck naoeco

    gacncco apknaikjljek pao{cgk~ nk nca}ch*}qich tcgk~ ~a}tamq~ icgc p}jfatk nk

    }qich tcgk~ ~a}tamq~ ucbkm iaimqc~ Pconqco P}cg~kg Glkokt (PPG+ qo~qg }qich

    tcgk~ ~a}tamq~ nco nktchgco paoeeqoccoo{c nk }qich tcgk~ jlah nk}ag~q} }qich

    tcgk~/ Nclci iao{qtqo POPG nc}k j}ecoktctk p}jfatk icqpqo PPG qo~qg }qich

    36 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]*KX*=030

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    12/32

    ;

    tcgk~ ) p}jfatk iankt iaima}kgco palc{coco gap}jfatkcoo{c tadc}c afag~kf (dlkokdcl

    affad~kvaoatt+ nclci hcl iaoaecggco nkceojtkt nco iaima}kgco ~a}cpk

    ma}nctc}gco paonagc~co avknaoda)mctan iankdkoa / Tadc}c tana}hcoc pa}c~q}co

    ~a}tamq~ ncpc~ nklkhc~ tamceckicoc nclci Ecimc} > ma}kgq~/

    Ecimc} >/ ]koegctco Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]* KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}co POPG,TPJ nco PPG/

    P}jtat talcobq~o{c ta~alch iao{qtqo Pconqco P}cg~kg Glkokt (PPG+ ]qich Tcgk~

    cnclch iaimqc~ Dlkokdcl Pc~huc{t tamceck tclch tc~q gjipjoao nc}k Tkt~ai

    Dctaikx (KOC DME+ {coe tcc~ kok nkpa}eqocgco qo~qg Bcikoco Paialkhc}cco

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    13/32

    30

    Gatahc~co (Bcigatict+ nk }qich tcgk~ ) icgc KOC DME cgco lamkh

    nktaipq}ocgco naoeco iaoehk~qoe N]E ]alc~kva Uakeh~ nco Dctaikx Konax

    ta}~c Mcta ]c~a ta~kcp paoealjipjggco baokt pao{cgk~ nco talcobq~o{c ncpc~

    iaimconkoegco (maodhic}gkoe+ djt~ affkdkaod{ co~c} }qich tcgk~ nclci

    iaima}kgco lc{coco gatahc~co ma}nctc}gco gacncco tamaoc}o{c nkma}kgco ialclqk

    Dlkokdcl Pc~huc{t /

    Tkt~ai Dctaikx cnclch tqc~q dc}c iaoealjlc tqima} nc{c }qich tcgk~ taafag~kf

    iqoegko nclci iaima}kgco lc{coco gatahc~co {coe ~a}bcoegcq gapcnc

    ict{c}cgc~ ma}nctc}gco paoealjipjggco tpag~}qi nkceojtkt pao{cgk~ {coehjijeao nco p}jtanq} ~koncgco {coe nkma}kgco ) tadc}c }koegcto{c ~a}nk}k nc}k 4

    gjipjoao q~cic {cgok gjnafkgctk nkceojtkt (KDN 30+ nco p}jtanq} ~koncgco

    (KDN ; DI+, paimkc{cco ( djt~koe + {coe ncpc~ ma}qpc ~jp)njuo cpp}jcdh,

    cd~kvk~{ mctan djt~koe nco c~cq gjimkoctk ganqco{c, nco ialclqk Dlkokdcl

    Pc~huc{t /35,38,3;,=0,=3

    KOC)N]E cnclch vc}kctk tkt~ai dctaikx va}tk Gaiao~a}kco Gatahc~co ]K qo~qg

    Konjoatkc {coe nktqtqo ma}nctc}gco nc~c nc}k 31 }qich tcgk~ va}~kgcl,

    iaipa}eqocgco KDN 30 qo~qg nkceojtkt nco KDN ; DI qo~qg p}jtanq} ~koncgco

    ta}~c mkc{c ma}nctc}gco ~c}kf {coe ma}lcgq pcnc ucg~q ~a}tamq~/ Qpc{c ~a}tamq~

    iaicoe malqi taipq}oc nco malqi iaoda}ikogco }aclk~ct gacncco talq}qh

    paljtjg ~coch ck} ociqo tamceck ~k~kg ~joeecg cucl, hcl ~a}tamq~ ia}qpcgco

    tqc~q gama}hctklco nclci iaimqc~ tqc~q tkt~ai paimkc{cco lc{coco gatahc~co

    }qich tcgk~ nco qtchc mckg iaoqbq gapct~kco nco ncpc~ nkpa}mckgk ta}~c

    nk~koegc~gco gqclk~ct icqpqo vclknk~ct nc~co{c {coe }ap}atao~c~kf qo~qg Konjoatkc/

    35 Ejlnico L/ Djt~)Affad~kvaoatt ko c flc~ uj}ln Dco KDNt halp ~ha Qok~an T~c~at ea~ }h{~hi: O Aoel B Ian =0017414(3> +23134)1/

    38 Ncoc M Iqgcia NM, Rucorkea} B, Mciarck C/ Hjtpk~cl djipa~k~kjo, }atjq}da clljdc~kjo consqclk~{ jf dc}a/ MID Hacl~h Ta}vkdat ]atac}dh =00=7 =(30+2 3>5=)83/

    3; Nkcoa ]julcon N/ Iankdckn Kiplkdc~kjot fj} ~ha hacl~h tcfa~{ oa~/ O Aoel B Ian =0017414(3>+2 3>4;)>3/

    =0 E}acll{ D/ Cf~a} 3= {ac}t jf Dctaikx ko K}alcon, c icbj} }avkau lacnkoe ~j k~t ijna}oktc~kjo conaxpcotkjo ct c dao~}cl pkllc} ko hjtpk~cl fqonkoe pjlkd{/ K}alcon Napc}~iao~ jf Hacl~h, =00>/

    =3 Dctaikx Qok~ Napc}~iao~ jf Hacl~h con Dhkln}ao/ Dctaikx Iactq}aiao~ ko K}kth Hjtpk~clt/K}alcon Napc}~iao~ jf Hacl~h, =001/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    14/32

    33

    Tamceck tkt~ai {coe mc}q lchk} KOC)N]E cgco ~a}qt ma}eqlk} nco ma}gaimcoe

    tatqck ~qo~q~co pa}gaimcoeco lc{coco gatahc~co mckg octkjocl icqpqo }aekjocl/ ==

    Naoeco ma}cghk}o{c lktaotk e}jqpa} KOC)N]E ~a}hk~qoe ~coeecl 40 Tap~aima}

    =030, icgc ocic tk~ai Dctaikx KOC)N]E ma}qmch iaobcnk KOC)DME =4/

    P=BG Gaiao~a}kco Gatahc~co ]K ~alch iaoecncgco pa}~aiqco naoeco talq}qh

    pa}hkipqoco p}jfatk nco gjlaekqi nk Naopctc} Mclk pcnc ~coeecl =4 Ojvaima}

    =00; nco iaoehctklgco gapq~qtco tamceck ma}kgq~2

    3/ Gatapcgc~co nco gjik~iao ma}tcic talq}qh pa}hkipqoco p}jfatk nco

    Gjlaekqi ta~kcp pa}hkipqoco p}jfatk iaimqc~ 30 pao{cgk~ ~a}mco{cg

    T~conc}*Panjico Palc{coco Iankt (T*PPI+ nco Dlkokdcl Pc~huc{t qo~qg

    ialaoegcpk KOC)N]E nclci P}je}ci Bcikoco Gatahc~co/

    =/ Pa}~aiqco talcobq~o{c ~coeecl == Bcoqc}k =030 nktalaoeec}cgco jlah Pqtc~

    Paimkc{cco nco Bcikoco Gatahc~co (P=BG+ Tag}a~c}kc~ Baona}cl Napgat

    ]K iaimchct talq}qh TPI nco DP/

    ]aodcoc pa}~aiqco lcobq~co ~coeecl == Bcoqc}k =030 nkqonq} nco ~a}aclktctk pcnc

    ~coeecl 5); Cp}kl =030 nk Mc~ci naoeco paimchctco gaimclk iaoeaock T~conc}

    Palc{coco Ganjg~a}co ta~kcp pa}hkipqoco p}jfatk/ Nc}k pa}~aiqco nkhc}cpgco

    nkhctklgco tqc~q T~conc} Palc{coco Ganjg~a}co ~koegc~ octkjocl {coe nktamq~

    Pconqco Octkjocl P}cg~kg Ganjg~a}co (POPG+ tamceckicoc {coe nkhc}cpgco nc}k

    Pa}c~q}co Iao~a}k Gatahc~co Ojij} 3>48*IAOGAT*PA]*KX*=030 ~ao~coe

    T~conc} Palc{coco Ganjg~a}co {coe cgco iaobcnk cdqco p}jfatk nk }qich tcgk~

    qo~qg iaimqc~ Pconqco P}cg~kg Glkokt (PPG+ ictkoe ictkoe/

    == Fk}iconc N/ Coclktkt Paimc{c}co gapcnc Paima}k Lc{coco Gatahc~co (PPG+ iaoeeqocgcoKOC)DME iaonagc~k hc}cpco taiqc pkhcg tatqck Dlkokdcl Pc~huc{t / Nktcipckgco pcncUj}gthjp Kiplaiao~ctk KOC)DME Pa}dapc~co ^}cotfj}ictk nk ]qich Tcgk~ Nca}ch (]TN+nktalaoeec}cgco jlah Ctjtkctk ]qich Tcgk~ Nca}ch Talq}qh Konjoatkc (C]TCNC+ Bcuc Mc}c~ nkHj~al Ct~jo ^}jpkdcoc Mconqoe, =4 Bqok =033/=4 Tq}c~ Anc}co Nk}ag~q} Baona}cl Mkoc Palc{coco Iankg Gaiao~a}kco Gatahc~co ]K Ojij} K]/04/03* K*150530 ^coeecl 38 Jg~jma} =030/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    15/32

    3=

    T~conc} Palc{coco Ganjg~a}co => cnclch panjico {coe hc}qt nkkgq~k jlah njg~a}

    nclci iao{alaoeec}cgco p}cg~kg ganjg~a}co =1 nco tclch tc~q ~koncg lcobq~ nc}k

    pa}qoncoeco {coe ~alch nk~a}mk~gcoaoci ~chqo {coe lclq/ =6 T~conc} Palc{coco

    Ganjg~a}co ~a}nk}k nc}k Panjico Octkjocl Palc{coco Ganjg~a}co (POPG+ nco

    T~conc} P}jtanq}cl Jpa}ctkjocl (TPJ+/ =5

    Pa}co Gjik~a Iankg cnclch iaoegj}nkoctkgco pao{qtqoco Pconqco P}cg~kg

    Glkokt (PPG+ {coe nkmqc~ jlah (galjipjg+ t~cf iankt =8 nco iaoecdq gapcnc

    Panjico Octkjocl Palc{coco Ganjg~a}co (POPG+ {coe nkmqc~ jlah j}ecoktctk

    p}jfatk =; nco nktchgco jlah Iao~a}k Gatahc~co 6/ Naoeco ~a}mk~o{c Pa}c~q}co

    Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]*KX*=030 {coe nkeqocgco

    cnclch kt~klch T~conc} Palc{coco Ganjg~a}co (TPG+ {coe ~a}nk}k nc}k Panjico

    Octkjocl Palc{coco Ganjg~a}co (POPG+ nco T~conc} P}jtanq} Jpa}ctkjocl (TPJ+/

    POPG nkmqc~ jlah j}ecoktctk p}jfatk nco nktchgco jlah Iao~a}k Gatahc~co ]K,

    tancoegco TPJ nkmqc~ nk ~koegc~ }qich tcgk~ jlah p}jfatk iankt naoeco

    gjj}nkoc~j} Gjik~a Iankg nco nk~a~cpgco paoeeqoccoo{c nk }qich tcgk~

    ~a}tamq~ jlah pkipkoco (nk}ag~q}+/

    T~conc} Palc{coco Ganjg~a}co (POPG nco PPG+ ~kncg knao~kg naoeco Mqgq Cbc},

    ^ax~)mjjgt c~cqpqo dc~c~co gqlkch {coe nkeqocgco nk pa}eq}qco ~koeek/ Gc}aoc

    T~conc} Palc{coco Ganjg~a}co ia}qpcgco clc~*mchco {coe nkkiplaiao~ctkgco

    pcnc pctkao7 tancoegco mqgq cbc}, ~ax~)mjjgt, bq}ocl, mchco taikoc} icqpqo

    paoeclcico p}kmcnk cnclch tamceck mchco }qbqgco*}afa}aotk nclci iao{qtqo

    T~conc} Palc{coco Ganjg~a}co/

    => Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}co/h~~p2**uuu/td}kmn/dji*njd*>4050564*Njn{)Fk}iconc)=030)Pa}iaogat)Oj)3>48)IAOGAT)

    PA])KX) =030)T~conc})Palc{coco)Ganjg~a}co=1 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 3 c{c~ 3/=6 Qoncoe Qoncoe ]K Ojij} =; ^chqo =00> Pctcl >> c{c~ 4/=5 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 4 c{c~ 3/=8 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 33/=; Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 3>48*KX*=030 ~ao~coe T~conc} Palc{coco Ganjg~a}coPctcl 4 nco Pctcl 6/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    16/32

    34

    T~conc} P}jtanq} Jpa}ctkjocl qo~qg p}jfatk iankt nk }qich tcgk~ nclci mao~qg

    Pconqco P}cg~kg Glkokt40 ) pcnc qiqio{c ncpc~ nkcnjptk nc}k Pconqco Octkjocl

    Palc{coco Ganjg~a}co (POPG+ {coe ~alch nkmqc~ jlah j}ecoktctk p}jfatk ictkoe

    ictkoe, ~koeecl nkdjdjggco nco nktatqckgco naoeco gjonktk tc}coc nco

    gjipa~aotk {coe cnc nk }qich tcgk~/ Mklc POPG {coe ~alch nkmqc~ jlah j}ecoktctk

    p}jfatk ~a}tamq~ nco ~alch nktchgco jlah Iao~a}k Gatahc~co ]K ta}~c tatqck naoeco

    gjonktk }qich tcgk~ icgc ~koeecl nktapcgc~k jlah coeej~c p}jfatk (TIF+ ~a}gck~

    tamceck Pconqco P}cg~kg Glkokt (PPG+ nco nktchgco paoeeqoccoo{c nk }qich

    tcgk~ jlah nk}ag~q} }qich tcgk~ ~a}tamq~/

    Ociqo mklc POPG ~a}tamq~ malqi cnc c~cq ~kncg tatqck naoeco gjonktk }qich

    tcgk~ c~cq nclci POPG malqi iaodco~qigco baokt pao{cgk~ {coe tatqck naoeco

    gacncco apknaikjljek pao{cgk~ nk nca}ch*}qich tcgk~ ~a}tamq~ icgc p}jfatk nk

    }qich tcgk~ ~a}tamq~ ucbkm iaimqc~ Pconqco P}cg~kg Glkokt (PPG+ qo~qg }qich

    tcgk~ ~a}tamq~ nco nktchgco paoeeqoccoo{c nk }qich tcgk~ jlah nk}ag~q} }qich

    tcgk~/ Nclci iao{qtqo POPG nc}k j}ecoktctk p}jfatk icqpqo PPG qo~qg }qich

    tcgk~ ) p}jfatk iankt iaima}kgco palc{coco gap}jfatkcoo{c tadc}c afag~kf (dlkokdcl

    affad~kvaoatt+ nclci hcl iaoaecggco nkceojtkt nco iaima}kgco ~a}cpk

    ma}nctc}gco paonagc~co avknaoda)mctan iankdkoa /

    Pa}co Gjik~a Iankg nktkok cnclch2

    3/ iaimqc~ nco iaoa~cpgco fj}ic~ qiqi Pconqco P}cg~kg Glkokt

    =/ iaoa~cpgco gatapcgc~co ~koegc~ avknaot {coe cgco nkpa}eqocgco nk ]T

    4/ iaoegjipklctk PPG {coe ~alch talatck

    >/ ia}agjiaonctkgco PPG gapcnc nk}ag~q} qo~qg paoeatchco paoeeqocco

    PPG ~a}tamq~ nk }qich tcgk~

    1/ ialcgtcocgco cqnk~ iankt naoeco iaipa}eqocgco PPG

    6/ iaoa~cpgco gauaocoeco glkokt p}jfatk iankt

    40 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 34>8*IAOGAT*PA]*KX*=030

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    17/32

    3>

    Naoeco ~a}mk~o{c Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033,

    icgc Gapq~qtco Iao~a}k Gatahc~co Ojij} 55=*Iaogat*TG*VK*=00= ~ao~coe

    Panjico Pa}c~q}co Ko~a}ocl ]qich Tcgk~ ( Hjtpk~cl M{ Lcut+ tapcobcoe iaoeaock

    paoec~q}co t~cf iankt, Gapq~qtco Iao~a}k Gatahc~co Ojij}

    >;6*Iaogat*TG*KV*=001 ~ao~coe Panjico Cqnk~ Iankt nco Gapq~qtco Iao~a}k

    Gatahc~co Ojij} 643*Iaogat*TG*VKK*=001 ~ao~coe Panjico Pao{qtqoco

    Pa}c~q}co Ko~a}ocl T~cf Iankt nkdcmq~ nco nko{c~cgco ~kncg ma}lcgq43 nco ta~kcp

    }qich tcgk~ hc}qt iao{atqckgco naoeco pa}c~q}co ~a}tamq~ talcimc~o{c ~coeecl 1

    Ojvaima} =033 (6 mqlco tabcg nkqoncoegcoo{c pa}c~q}co ~a}tamq~+4=/

    Pa}c~q}co Iao~a}k Gatahc~co ~a}tamq~ ma}~qbqco qo~qg iaoec~q} ~c~c galjlc glkokt

    (dlkokdcl ejva}ocoda + {coe mckg cec} iq~q palc{coco iankt nco gatalcic~co

    pctkao nk}qich tcgk~ lamkh ~a}bciko nco ~a}lkonqoek ta}~c iaoec~q}

    pao{alaoeec}cco gjik~a iankg nk ta~kcp }qich tcgk~ nclci }coegc paokoegc~co

    p}jfatkjoclktia t~cf iankt/ 44 Tahkoeec tqnch talc{cgo{c ta~kcp }qich tcgk~

    iaimqc~ ^c~c Galjlc Gj}pj}c~ ( Dj}pj}c~a Ejva}ocoda+ nco ^c~c Galjlc Glkokt

    (Dlkokdcl Ejva}ocoda+ tamceck gjotagqaotk ~koncg lcobq~ nc}k Pa}c~q}co Ko~a}oc

    T~cf Iankt (Iankdcl T~cf M{lcut+ nco Pa}c~q}co Ko~a}oc ]qich Tcgk~ (Hjtpk~cl

    M{lcut+/

    ^a}lapct nc}k gaonclc paoeeqocco Dlkokdcl Pc~huc{t tamceck palaoegcp KOC)

    DME7 kiplaiao~ctk Dlkokdcl Pc~huc{t tcoec~ ma}icofcc~ mcek p}jfatk nclci

    iaima}kgco palc{coco, paonknkgco icqpqo paoalk~kco nk }qich tcgk~

    tamceckicoc ncpc~ nklkhc~ nclci ecimc} 1 tcipck 5 ma}kgq~/

    43 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033 Pctcl =0/4= Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033 Pctcl 3;/44 Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij} 511*Iaogat*KV*=033 Pctcl =/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    18/32

    31

    Ecimc} 1/ Kiplaiao~ctk Dlkokdcl Pc~huc{t nclci mkncoe palc{coco nk }qich

    tcgk~/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    19/32

    36

    Ecimc} 6/ Kiplaiao~ctk Dlkokdcl Pc~huc{t qo~qg paoalk~kco nk }qich tcgk~/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    20/32

    35

    Ecimc} 5/ Kiplaiao~ctk Dlkokdcl Pc~huc{t nkgck~co naoeco ctatiao paoklckcoqo~qg pata}~c nknkg ichctktuc nco pata}~c p}je}ci njg~a} tpatkclkt nk }qich tcgk~icqpqo }qich tcgk~ babc}koe paonknkgco/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    21/32

    38

    Gjotap/ gjot~}qgtk icqpqo ijnal kiplaiao~ctk Dlkokdcl Pc~huc{t tadc}c ~kncg

    lcoetqoe tamceckicoc nkq~c}cgco nkc~ct mchuc2

    Dlkokdcl Pc~huc{t tamceck kot~}qiao palc{coco ma}fjgqt gapcnc pctkao

    (pc~kao~)fjdqtan dc}a+ , ~a}ko~ae}ctk, ma}gatkocimqoeco nc}k pctkao

    ictqg nk}cuc~ tcipck pqlcoe taimqh (djo~koqjqt dc}a+, balct cgco

    njg~a}*pa}cuc~ paocoeeqoe bcucm pctkao (NPBP*PPBP+ tamceck nq~{ jf

    dc}a, q~klk~ct paia}kgtcco paoqobcoe, paoeeqocco jmc~ jmc~co ~a}ictqg

    co~kmkj~kgc, p}jtanq} ~koncgco jpa}ctk, co~ktkpctk gaiqoegkoco ~a}bcnko{c

    iankdcl a}}j}t (lc~ao nco cg~kf, o{c}kt ~a}bcnk icqpqo gabcnkco ~kncg

    nkhc}cpgco*G^N+ nco paodaechco gaiqoegkoco dana}c (hc}it+ ta}~c

    kofagtk ojtjgjikcl nclci }coegc gatalcic~co pctkao (pc~kao~ tcfa~{+,

    iaona~agtk nkok ~k~kg ~k~kg pj~aotkcl ma}ktkgj talcic p}jtat lc{coco

    pa}cuc~co pctkao (~}cda}t ia~hjnjlje{+ nclci }coegc icocbaiao }ktkgj

    (}ktgt icoceaiao~+, }aodcoc paiqlcoeco pctkao (pc~kao~ nktdhc}ea+,

    qpc{c paokoegc~co iq~q lc{coco ma}gatkocimqoeco (djo~koqjqt sqclk~{

    kip}jvaiao~+ mckg naoeco paonagc~co ~ahokg ^JD (^haj}{ jf Djot~}cko~t+

    qo~qg tkt~ai icqpqo konkvknq p}jfatk, paoqlqtq}co gkoa}bc (pa}fj}icoda+

    konkvknq p}jfatk icqpqo galjipjg (~aci)uj}g+/

    Ia}qpcgco tqc~q }coegckco tkt~ai {coe ncpc~ nkpa}eqocgco tamceck kot~}qiao

    qo~qg iaiaoqhk pa}t{c}c~co paoklckco Cg}ank~ctk nc}k Gjik~a Cg}ank~ctk ]qich

    Tcgk~ (GC]T+ va}tk mc}q icqpqo nc}k Bjko~ Djiikttkjo Ko~a}oc~kjocl fj}

    Hjtpk~cl (BDK+va}tk =033 qo~qg t~conc} t~conc} nclci Tad~kjo K/ Pc~kao~ Dao~a}an

    T~conc}n icqpqo nclci Tad~kjo KK/ Hacl~hdc}a J}ecokrc~kjo Icoceaiao~ T~conc}n tamceckicoc klqt~}ctk Ecimc} 8 tcipck 30 ma}kgq~/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    22/32

    3;

    Ecimc} 8/ Dlkokdcl Pc~huc{t nco va}tk BDK =033 Cdd}ank~c~kjo T~conc}nt

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    23/32

    =0

    Ecimc} ;/ Tkt~aic~kgc nclci va}tk BDK =033 Hjtpk~cl T~conc}nt nco Paoklckcoo{c

    Oj~Ia~

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    24/32

    =3

    Ecimc} 30/ Dlkokdcl Pc~huc{t nco ~ahokg ^}cda} Ia~hjnjlje{ {coe nkeqocgcojlah tq}vakj} nclci }coegc Cg}ank~ctk va}tk BDK =033

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    25/32

    ==

    P}kotkp p}kotkp nclci iao{qtqo Dlkokdcl Pc~huc{t

    Dlkokdcl Pc~huc{t (DP+ cnclch tqc~q gjotap pa}aodcocco palc{coco ~a}pcnq

    {coe ia}coegqi ta~kcp lcoegch {coe nkma}kgco gapcnc pctkao ma}nctc}gco

    t~conc} palc{coco iankt nco ctqhco gapa}cuc~co {coe ma}mctkt mqg~k naoeco

    hctkl {coe ~a}qgq} nco nclci bcoegc ucg~q ~a}~ao~q talcic nk }qich tcgk~/ 4>,41,46

    Nclci iaimqc~ Dlkokdcl Pc~huc{t paocoecoco gctqt pctkao }cuc~ kocp nk }qich

    tcgk~ hc}qt ma}tkfc~2

    c/ Talq}qh gaekc~co palc{coco {coe nkma}kgco hc}qt tadc}c ~a}pcnq*ko~ae}ctk

    nco ma}j}kao~ctk fjgqt ~a}hcncp pctkao (Pc~kao~ Fjdqtan Dc}a+ ta}~c

    ma}gatkocimqoeco (djo~koqjqt jf dc}a+

    m/ Ialkmc~gco talq}qh p}jfatk (njg~a}, pa}cuc~*mknco, paoc~c, lcmj}c~j}kt nco

    fc}ictkt+

    d/ Nclci mc~ctco ucg~q {coe ~alch nk~ao~qgco tatqck naoeco gacncco

    pa}bclcoco pao{cgk~ pctkao nco nkdc~c~ nclci mao~qg pa}kjna hc}kco (qo~qg

    gctqt }cuc~ kocp+ c~cq bci (qo~qg gctqt ecuc~ nc}q}c~ nk qok~ aia}eaotk+/

    n/ Paodc~c~co DP talq}qh gaekc~co palc{coco {coe nkma}kgco gapcnc pctkao

    tadc}c ~a}pcnq nco ma}gatkocimqoeco ~a}tamq~ nclci mao~qg njgqiao

    {coe ia}qpcgco mcekco nc}k ]agci Iankt/

    a/ Ta~kcp pao{kipcoeco lcoegch nclci paoa}cpco DP nkdc~c~ tamceck vc}kcot

    nco nklcgqgco gcbkco coclktkt nclci mao~qg cqnk~/

    f/ Vc}kcot ~a}tamq~ ncpc~ gc}aoc gjonktk pa}bclcoco pao{cgk~, pao{cgk~

    pao{a}~c c~cq gjiplkgctk icqpqo gatclchco iankt (iankdcl a}}j}t+ /

    4> Fk}iconc N/ Panjico Pao{qtqoco Dlkokdcl Pc~huc{t nclci }coegc kiplaiao~ctk Tkt~ai N]EtDctaikx nk }qich tcgk~/ Nktcipckgco nclci Tkncoe Plaoj Gjik~a Iankg ]T Fc~icuc~k, Bcgc}~c

    5 Jg~jma} =001/41 Fk}iconc N/ Dlkokdcl Pc~huc{t2 Pa}co p}jfatk iankt nclci }coegc iao{qtqo Tkt~ai N]Et

    Dctaikx nk }qich tcgk~/ Nktcipcgco pcnc gqobqoeco lcpcoeco ga ]TQP Cnci Iclkg Ianco== Nataima} =001, ]TQP Hctco Tcnkgko Mconqoe =4 Nataima} =001 nco Avclqctk Pao{qtqocoDlkokdcl Pc~huc{t nclci }coegc pao{aipq}occo Panjico N]Et Dctaikx Napgat ]K, Hj~alE}con Daipcgc Bcgc}~c =; Nataima} =001/

    46 Fk}iconc N, P}c~kuk Conc{cok, Oq}ckok K}ic Tqtco~k, T}ka Aoeec} GN ngg/ Dlkokdcl Pc~huc{tGatahc~co Cocg nclci }coegc kiplaiao~ctk Tkt~ai N]Et Dctaikx nk ]T Fc~icuc~k, Bcgc}~c

    =006/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    26/32

    =4

    e/ Vc}kcot ~a}tamq~ nkpa}eqocgco tamceck tclch tc~q pc}cia~a} nclci }coegc

    iaipa}~chcogco nco iaokoegc~gco iq~q palc{coco/

    Dlkokdcl Pc~huc{t ~a}tamq~ ncpc~ ia}qpcgco tqc~q T~conc} P}jtanq} Jpa}ctkjocl

    {coe ia}coegqi2

    c/ P}jfatk iankt2 T~conc} Palc{coco Iankt nc}k ta~kcp Galjipjg T~cf

    Iankt*T~cf Iankt Fqoetkjocl (TIF+ glkokt nco paoqobcoe/

    m/ P}jfatk gapa}cuc~co2 Ctqhco Gapa}cuc~co

    d/ P}jfatk fc}ictk2 Qok~ Njta Nckl{ nco T~jp J}na}koe

    n/ Clq} Palc{coco Pctkao ]cuc~ Kocp nco Jpa}ctk nc}k Tkt~ai Galjipjg T~cf Iankt*T~cf Iankt Fqoetkjocl (TIF+, Kot~clctk nco Tkt~ai Icocbaiao

    ]qich Tcgk~/

    Lcoegch lcoegch pao{qtqoco Dlkokdcl Pc~huc{t

    Lcoegch lcoegch nclci iao{qtqo Fj}ic~ Dlkokdcl Pc~huc{t {coe hc}qt

    nkpa}hc~kgco2

    3/ Gjipjoao {coe hc}qt nkdcgqp tamceckicoc nafkoktk nc}k Dlkokdcl

    Pc~huc{t

    =/ Icofcc~gco nc~c {coe ~alch cnc nk lcpcoeco }qich tcgk~ nco gjonktk

    ta~aipc~ 45 tapa}~k nc~c Lcpj}co ]L= (Nc~c Gacncco Ij}mknk~ct Pctkao+

    {coe nkmqc~ ta~kcp }qich tcgk~ ma}nctc}gco Mqgq Pa~qobqg Paoektkco,

    Paoejlchco nco Pao{cbkco Nc~c ]qich Tcgk~ 48 nco taotqt hc}kco qo~qg2

    c/ Paoa~cpco bqnql*~jpkg Dlkokdcl Pc~huc{t {coe cgco nkmqc~/

    m/ Paoa~cpco lcic hc}k }cuc~/

    45 Fk}iconc N/ Gjnafkgctk KDN 30 nco KDN ; DI2 konkgc~j} iq~q }agci iankg nclci }coegciaokoegc~gco iq~q palc{coco }qich tcgk~/ Nktcipckgco pcnc Tjtkclktctk Pjlc Tkt~ai

    Kofj}ictk Icocbaiao ]qich Tcgk~ / Nktalaoeec}cgco jlah Nk}ag~j}c~ Baona}cl Mkoc Palc{coco Iankg

    Napgat ]Knk Hj~al Pcoehaec} Mconqoe 3)4 Bqok =006/

    48 Napc}~aiao Gatahc~co ]K/ Mqgq Pa~qobqg Paoektkco, Paoejlchco nco Pao{cbkco Nc~c ]qichTcgk~/ Nk}ag~j}c~ Baona}cl Mkoc Palc{coco Iankg Napgat ]K, Bcgc}~c =001/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    27/32

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    28/32

    =1

    Ta~kcp vc}kcot {coe nkncpc~gco cgco nklcgqgco ~koncg lcobq~ nclci mao~qg

    palcgtcocco cqnk~ iankt tamceckicoc {coe nkcobq}gco nclci Qoncoe Qoncoe ]K

    Ojij} =; ^chqo =00> nco Pa}c~q}co Iao~a}k Gatahc~co ]K Ojij}

    511*Iaogat*Pa}*KV*=033/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    29/32

    =6

    Gatkipqlco2

    Nc}k q}ckco tkoegc~ nkc~ct naoeco hco{c talaimc} Dlkokdcl Pc~huc{t )

    ia}qpcgco tqc~q kot~}qiao {coe gjip}ahaotkf ia}coegqi tadc}c ~a}pcnq mkncoe

    palc{coco, paonknkgco nco paoalk~kco icqpqo cg}ank~ctk ta}~c mklc nk~kobcq

    nc}k taek agjojik gatahc~co ncpc~ ialcgtcocgco afktkaotk paimkc{cco naoeco

    iaicofcc~gco tajp~kicl iqoegko hc}k }cuc~ pctkao, iaoealkikoctk paia}kgtcco

    paoqobcoe*lcmj}c~j}kqi*~koncgco {coe ~kncg nkpa}lqgco, iaoeeqocgco jmc~

    jmc~cco (~a}q~cic co~kmkj~kg+ tatqckavknaoda)mctan7 tahkoeec palc{coco afag~kf

    nktcipkoe ~kncg iaimancgco lc~c} malcgcoe pctkao gc}aoc fjgqt gapcnc pctkao

    nco pao{cgk~o{c (gama}cnklco*agqk~k+ nco tagclkeqt iaiaoqhk talq}qh ~kec~qbqco nc}k Qoncoe Qoncoe ]K Ojij} =; ^chqo =00> nco aipc~ ~qbqco

    Qoncoe Qoncoe ]K Ojij} >> ^chqo =00;/

    Naikgkco pqlc mcek ]qich Tcgk~ Paonknkgco, Dlkokdcl Pc~huc{t ncpc~

    nkpa}eqocgco tamceck kot~}qiao nclci Iankdcl Anqdc~kjo Cttattiao~t ~koegc~

    glkokt nclci mao~qg Uj}gplcda)mctan Cttattiao~ (UMC+ qo~qg Lje)mjjg, Ikok)

    DAX, NJPT, Dm)N, 460)nae}aa Cttattiao~ (Ikok)PC^+, Pj}~fjlkj nco Td}kp~

    Djodj}ncoda ^at~ (TD^+ {coe tqnch ia}qpcgco gjipjoao nclci Cg}ank~ctk

    T~conc} Paonknkgco Njg~a} nco Njg~a} Tpatkclkt nk Konjoatkc/

    Mchgco mklc nklcgtcocgco Dlkokdcl Pc~huc{t tadc}c gjotkt~ao nkicoc cgco

    nkncpc~gco nc~c nc~cdjt~)uakeh~, dctaikx konax nco mcta)}c~a tadc}c laoegcp

    (qo~qg ikd}j)t{t~ai + cgco ncpc~ nktqtqo tqc~q Oc~kjocl Hacl~h Cddjqo~t tahkoeec

    Qokva}tcl Djva}cea cgco lamkh iqnch ~a}dkp~c nco Qoncoe Qoncoe ]K Ojij}

    >0 ^chqo =00> ta}~c Qoncoe Qoncoe ]K Ojij} => ^chqo =033 qo~qg mkncoe

    gatahc~co ~a}uqbqn (tadc}c icd}j)t{t~ai +/

    ^a}kic gctkh, taijec ma}icofcc~/Tq}cmc{c, 8 Nataima} =03=Njn{ Fk}iconcGa~qc Gjik~a Iankg ]TQP Fc~icuc~k Bcgc}~c/h~~p2**uuu/td}kmn/dji*Gjik~a!=0Iankg

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    30/32

    =5

    LCIPK]CO2

    PCONQCO P]CG^KG GLKOKT (PPG+

    ]TQN N] IJHCICN TQUCONHKATQ]CMC[C BCUC ^KIQ]

    =03= =03>

    //////////////////////////////

    3/ Paoea}~kco (Nafkoktk+

    =/ Cocioatkt

    4/ Paia}kgtcco Fktkg

    >/ G}k~a}kc Nkceojtkt 3/ =/ 4/ >/ 1/ /////

    1/ Nkceojtkt 6/ Nkceojtkt Mconkoe 3/

    =/ 4/

    5/ Paia}kgtcco Paoqobcoe 3/ =/ 4/ >/

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    31/32

    =8

    8/ ^a}cpk 3/ =/ 4/ >/ 1/ /////

    ;/ Anqgctk 3/ =/ 4/ >/ 1/ /////

    30/ P}jeojtkt Cn vk~ci 2 nqmkc cn mjoci*iclci

    Cn tcoc~kjoci 2 nqmkc cn mjoci*iclciCn fqietkjoci 2 nqmkc cn mjoci*iclci33/ ^koegc~ Avknaot K*KK*KKK*KV3=/ ^koegc~ ]agjiaonctk C*M*D34/ Paoalcch G}k~kt 3/

    =/ 4/ >/

    3>/ Konkgc~j} Iankt

    31/ Gapqt~cgcco 3/ =/ 4/ >/ 1/ /////

    Tq}cmc{c, /=03=

    Ga~qc Gjik~a Iankg Ga~qc TIF///////////////////////////////////////////////

    //////////////////////////////////// //////////////////////////////////////

    Nk}ag~q} ]TQN N} Ijhcicn Tquconka, Tq}cmc{cBcuc ^kiq}

    ///////////////////////////////////////////////////////

  • 7/30/2019 Dody Firmanda 2012 - Materi Pelatihan Clinical Pathways RSUD Dr Mohamad Suwandhie Surabaya 8-9 Desember

    32/32

    40

    DLKOKDCL PC^HUC[T

    ]TQN N] IJHCICN TQUCONHKA GJ^C TQ]CMC[C

    /

    Ocic Pctkao2

    Qiq}2

    Ma}c~ Mcnco2//ge

    ^koeek Mcnco2//di

    Ojij} ]agci Iankt2/

    Nkceojtkt Cucl2 / Gjna KDN 30 2 ]aodcoc }cuc~ 2 hc}k

    Cg~kvk~ct Palc{coco]/ ]cuc~

    /^el*Bci ictqg2/

    ^el*Bci galqc}2/

    Lcic ]u~/// hc}k

    Galct2//

    ^c}kf*h} (]p+2/

    Mkc{c (]p+

    Hc}k ]cuc~ 3 Hc}k ]cuc~ = Hc}k ]cuc~ 4 Hc}k ]cuc~ > Hc}k ]cuc~ 1Hc}k Tcgk~2 Hc}k Tcgk~2 Hc}k Tcgk~2 Hc}k Tcgk~2 Hc}k Tcgk~2

    Nkceojtkt2

    Pao{cgk~ Q~cic / Pao{cgk~ Pao{a}~c / Gjiplkgctk /

    Ctattiao Glkokt2Paia}kgtcco njg~a} / //Gjotql~ctk / //

    Paia}kgtcco Paoqobcoe2 / //^koncgco2 / //Jmc~ jmc~co2

    //

    /

    /

    /

    ////

    //

    ////

    //

    ////

    //

    ////

    //

    Oq~}ktk2 / //Ijmklktctk2 / //Hctkl(Jq~djia+ 2

    // / // / // /

    Paonknkgco*]aodcocPaiqlcoeco2

    /

    Vc}kcot2 /

    Bqilch Mkc{c //Pa}cuc~ (PPBP+

    Nkceojtkt Cghk}2 Gjna KDN 30 Baokt koncgco2 Gjna KDN ;

    NPBP2

    Q~cic //

    NPBP Jpa}ctk2

    Pao{a}~c //

    NPBP Coat~atk///////////////////////

    / // //

    Va}kfkgc~j}2

    Gjiplkgctk // //